Tikun Olam-Cannbit and Wavelength strike novel cannabis agreement
![](/46/pdcnewsitem/11/37/62/HLN00CPO_pharma_partnership_990x525_scaled.jpg)
Firms say the partnership will "multiply the power of both companies, the pharmaceutical industry and the medical cannabis industry"
Tikun Olam-Cannbit and Wavelength have established a novel partnership to jointly develop, manufacture and market active cannabis-based raw materials for the pharmaceutical industry.
The partnership will target the global pharmaceutical market to capitalise on the regulatory changes regarding cannabis exports.
Through the partnership, Tikun Olam-Cannbit — one of Israel’s major medical cannabis brands, developing more than 42 proprietary strains and four licensed IPs — hopes to expand its footprint in the pharmaceutical arena.
Wavelength, also an Israeli company, develops, manufactures, and exports active pharmaceutical ingredients (APIs) to more than 280 pharmaceutical companies in 50 countries.
Initially, both parties' R&D specialists will work together to develop a method for producing the final products that respond to the current requirements of the pharmaceutical market.
After completing this development stage, Tikun Olam-Cannbit will provide the cannabis plants and extract the THC and/or CBD oil.
From its EU GMP and US FDA-certified plant in Neot Hovav, Wavelength will then processes the oils to bring the concentration of the THC and/or CBD to a pharma-grade level of purity, as required by pharmaceutical companies.
Avinoam Sapir, General Manager, Tikun Olam-Cannbit said the "unique" partnership will provide the company with "an opportunity to add another link to the emerging value chain between the medical cannabis industry and the pharmaceutical sector".
![Wavelength Pharmaceuticals](https://www.cphi-online.com/c272947th_S-comp272947.jpg)
Related News
-
Sponsored Content IFF Pharma Solutions: Paving the Way for Superior Suspensions
Shawn Branning, Global Strategic Marketing Manager at IFF – Pharma Solutions -
News Greenfield Global Ireland Ready to Supply Life Science Customers Globally
New facility aims to serve local and global pharmaceutical customers with high-purity ethanol, ethanol blends and buffer solutions -
News Rare diseases care pathway: a major challenge to harmonize patient management
In France, rare diseases are numerous: between 7,000 and 8,000 diseases are currently accounted for, and concern more than 3 million French people, accounting for almost 4,5% of the total population. The organization of screening and care for these ill... -
Sponsored Content CPHI Podcast Series: Selecting the Right CDMO Outsourcing Partner
Sponsors within the biopharmaceutical industry are increasingly turning to outsourcing for several reasons; remaining competitive and flexible within a quickly evolving sector, gaining access to manufacturing capacity and state-of-the-art equipment and... -
Sponsored Content Sterile manufacturing Annex 1 amendments: what, why and how explained
In January 2020 the European Commission published some proposed significant revisions to Annex 1, the EU’s good manufacturing practice (GMP) guide for the manufacture of sterile products. In the following three-month consultation period, affected... -
News Recipharm expands its analytical services offering in India
The CDMO inaugurates its new analytical laboratory under Recipharm Analytical Solutions -
News Pharmapack interviews Serkan Oray of UCB Pharma
Ahead of Pharmapack Europe 2021 in October, we talk to one of the speakers, Serkan Oray, Vice President, Devices, Packaging & Wearable Technologies at UCB Pharma about the company's new electromechanical injection device and the innovation drive wi... -
News Monosodium Phosphate 2-hydrate is now available with CEP
Dr. Paul Lohmann® recently received a CEP (Certificate of Suitability to the European Pharmacopoeia) for Monosodium Phosphate 2-hydrate, which enables a customer to register a drug in several countries in a cost-saving and simplified way. Since thi...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance